Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
New investors in 2023 must understand the current market landscape. Familiarize yourself with essential tips and strategies to thrive in investing.
28,353 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Berkshire Hathaway names Greg Abel as CEO, with Buffett signaling strong confidence as the company holds a cash-heavy...
CrowdStrike is set to report Q1 results after the close, with analysts expecting revenue around $1.39 billion and sol...
Elon Musk’s net worth surged above $1.1 trillion, driven by SpaceX and Tesla gains, rewriting the hierarchy at the ve...
A brief but frightening liquidity scare exposed vulnerabilities in the financial system. Regulators acted fast to con...
A Middle East crisis sent oil prices higher and spotlighted a rapid shift to electric vehicles. New data show the wor...
GameStop’s bid to acquire eBay is stirring a heated market debate over value and risk. Analysts say the move may be m...
The Procure Space ETF has delivered a standout 12-month return as investors chase growth in space-enabled industries....
Memory stocks exploded 1,000% last year as AI demand surged. Analysts say silver and copper could be next AI benefici...
Accenture warns AI’s carbon footprint could rise 11-fold by 2030 as data centers multiply worldwide. The piece examin...
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
QuantumScape stock rallies on the Eagle Line milestone and early customer billings, signaling a shift from research t...